PUBLISHER: Grand View Research | PRODUCT CODE: 1571460
PUBLISHER: Grand View Research | PRODUCT CODE: 1571460
The global laser capture microdissection market is anticipated to reach USD 329.0 million by 2030, growing at a CAGR of 8.37% from 2024 to 2030, according to a new report by Grand View Research, Inc. The increasing demand for precise and detailed cellular analysis across various research and clinical applications. The growing focus on personalized medicine, advancements in genomics and proteomics, and rising investments in cancer research are key factors fueling the market growth over the forecast period.
The COVID-19 pandemic has positively impacted the laser capture microdissection (LCM) market. The pandemic accelerated the adoption of precision medicine and advanced diagnostics, as researchers and healthcare professionals sought more detailed and accurate analytical tools. In addition, the growing focus on the virus has led to more research into how it works and the development of new diagnostic tools, increasing the demand for advanced technologies like LCM.
Moreover, the increasing funding for cancer research is significantly driving market growth. The growing investment is anticipated to enhance research capabilities and advancing technologies, thereby leading to increased adoption of laser capture microdissection for its precision in isolating specific cells and tissues for detailed analysis. Thus, researchers are better equipped to study cancer at a molecular level, leading to innovations in diagnostics and therapeutics.
However, the high cost is a significant factor anticipated to limit the adoption of LCM systems. The initial investment for LCM equipment is substantial, which can be a barrier for smaller laboratories or research settings with limited budgets. In addition to the high purchase price of the LCM systems, the costs for consumables such as slides, reagents, and other materials needed for each procedure are further expected to hamper the growth of the market.